Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 184, Issue 4, 2011, Pages 459-466

  Du Bois, Roland M ^a   Weycker, Derek ^b   Albera, Carlo ^c   Bradford, Williamson Z ^d   Costabel, Ulrich ^e   Kartashov, Alex ^b   Lancaster, Lisa ^f   Noble, Paul W ^g   Raghu, Ganesh ^h   Sahn, Steven A ⁱ   Szwarcberg, Javier ^d   Thomeer, Michiel ^j   Valeyre, Dominique ^k   King Jr , Talmadge E ^l  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b POLICY ANALYSIS INC PAI   (United States)

^c UNIVERSITY OF TURIN   (Italy)

^d InterMune Inc   (United States)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

^f VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^g DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

ⁱ MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^j UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^k AVICENNE HOSPITAL   (France)

^l UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Interstitial lung disease; Mortality; Risk factors; Vital capacity

Indexed keywords

CARBON MONOXIDE;

ADULT; AGE; AGED; ARTICLE; CLINICAL TRIAL (TOPIC); CONFIDENCE INTERVAL; CORRELATION COEFFICIENT; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; FORCED VITAL CAPACITY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; QUALITY OF LIFE; RISK ASSESSMENT; SCORING SYSTEM;

AGED; CARBON MONOXIDE; CLINICAL TRIALS AS TOPIC; FEMALE; HEALTH STATUS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PULMONARY DIFFUSING CAPACITY; QUALITY OF LIFE; RISK ASSESSMENT; TIME FACTORS; VITAL CAPACITY;

EID: 80051819865     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201011-1790OC     Document Type: Article

References (32)

1. American Thoracic Society. Idiopathic pulmonary fibrosis: Diagnosis and treatment. International consensus statement. American Thoracic Society (ATS) and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161:646-664.
2. King T.E. Jr., Albera C., Bradford W.Z., Costabel U., Hormel P., Lancaster L., Noble P.W., Sahn S.A., Szwarcberg J., Thomeer M., et al. Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): A multicentre, randomised, placebo-controlled trial. Lancet 2009;374:222-228.
3. Martinez F.J., Safrin S., Weycker D., Starko K.M., Bradford W.Z., King T.E. Jr., Flaherty K.R., Schwartz D.A., Noble P.W., Raghu G., et al. The clinical course of subjects with idiopathic pulmonary fibrosis. Ann Intern Med 2005;142:963-967.
4. King T.E. Jr., Tooze J.A., Schwarz M.I., Brown K., Cherniack R.M. Predicting survival in idiopathic pulmonary fibrosis: Scoring system and survival model. Am J Respir Crit Care Med 2001;164:1171-1181. (Pubitemid 33052246)
5. Wells A.U., Desai S.R., Rubens M.B., Goh N.S., Cramer D., Nicholson A.G., Colby T.V., du Bois R.M., Hansell D.M. Idiopathic pulmonary fibrosis: A composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med 2003;167:962-969. (Pubitemid 36408161)
6. Latsi P.I., du Bois R.M., Nicholson A.G., Colby T.V., Bisirtzoglou D., Nikolakopoulou A., Veeraraghavan S., Hansell D.M., Wells A.U. Fibrotic idiopathic interstitial pneumonia: The prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003;168:531-537. (Pubitemid 37088594)
7. Collard H.R., King T.E., Bartelson B.B., Vourlekis J.S., Schwarz M.I., Brown K.K. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003;168: 538-542. (Pubitemid 37088595)
8. Flaherty K.R., Mumford J.A., Murray S., Kazerooni E.A., Gross B.H., Colby T.V., Travis W.D., Flint A., Toews G.B., Lynch J.P. 3rd, et al. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003;168:543-548. (Pubitemid 37088596)
9. Flaherty K.R., Andrei A.C., Murray S., Fraley C., Colby T.V., Travis W.D., Lama V., Kazerooni E.A., Gross B.H., Toews G.B., et al. Idiopathic pulmonary fibrosis: Prognostic value of changes in physiology and six-minute- walk test. Am J Respir Crit Care Med 2006;174:803-809. (Pubitemid 44511662)
10. Lederer D.J., Arcasoy S.M., Wilt J.S., D'Ovidio F., Sonett J.R., Kawut S.M. Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006;174:659-664. (Pubitemid 44395333)
11. Lettieri C.J., Nathan S.D., Browning R.F., Barnett S.D., Ahmad S., Shorr A.F. The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis. Respir Med 2006;100:1734-1741. (Pubitemid 44283761)
12. Hamada K., Nagai S., Tanaka S., Handa T., Shigematsu M., Nagao T., Mishima M., Kitaichi M., Izumi T. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticators in patients with idiopathic pulmonary fibrosis. Chest 2007;131:650-656. (Pubitemid 46446853)
13. Alakhras M., Decker P.A., Nadrous H.F., Collazo-Clavell M., Ryu J.H. Body mass index and mortality in subjects with idiopathic pulmonary fibrosis. Chest 2007;131:1448-1453. (Pubitemid 46762351)
14. Best A.C., Meng J., Lynch A.M., Bozic C.M., Miller D., Grunwald G.K., Lynch D.A. Idiopathic pulmonary fibrosis: Physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality. Radiology 2008;246:935-940.
15. Kinder B.W., Brown K.K., Schwarz M.I., Ix J.H., Kervitsky A., King T.E. Jr., . Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis. Chest 2008;133:226-232.
16. Song J.W., Song J.K., Kim D.S. Echocardiography and brain natriuretic peptide as prognostic indicators in idiopathic pulmonary fibrosis. Respir Med 2009;103:180-186.
17. Caminati A., Bianchi A., Cassandro R., Mirenda M.R., Harari S. Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis. Respir Med 2009;103:117-123.
18. Zappala C.J., Latsi P.I., Nicholson A.G., Colby T.V., Cramer D., Renzoni E.A., Hansell D.M., du Bois R.M., Wells A.U. Marginal decline in FVC is associated with a poor outcome in idiopathic pulmonary fibrosis. Eur Respir J 2009;35:830-836.
19. du Bois R.M., Albera C., Bradford W.Z., Costabel U., Kartashov A., Noble P.W., Raghu G., Szwarcberg J., Thomeer M., Valeyre D. Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis [abstract]. Am J Respir Crit Care Med 2010;181:A2499.
20. Raghu G., Brown K.K., Bradford W.Z., Starko K., Noble P.W., Schwartz D.A., King T.E. Jr. A placebo-controlled trial of interferon gamma-1b in subjects with idiopathic pulmonary fibrosis. N Engl J Med 2004;350: 125-133. (Pubitemid 38056223)
21. Pencina M.J., D'Agostino R.B., D'Agostino R.B., Vasan R.S. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-172. (Pubitemid 351193639)
22. Allison P.D. Survival analysis using the SAS System: a practical guide. Cary, NC: SAS Institute Inc.; 1995. p. 292.
23. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-1847. (Pubitemid 28213628)
24. Pocock S.J., McCormack V., Gueyffier F., Boutitie F. Fagard R.H., Boissel JP. A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomized controlled trials. BMJ 2001;323:75-81. (Pubitemid 32681971)
25. Hippisley-Cox J., Coupland C., Vinogradova Y., Robson J., May M., Brindle P. Derivation and validation of QRISK: A new cardiovascular disease risk score for the UK: A new cardiovascular disease risk score for the UKProspective open cohort study. BMJ 2007;335:136.
26. Gries C.J., Rue T.C., Heagerty P.J., Edelman J.D., Mulligan M.S., Goss C.H. Development of a predictive model for long-term survival after lung transplantation and implications for the lung allocation score. J Heart Lung Transplant 2010;29:731-738.
27. Schnabel R.B., Sullivan L.M., Levy D., Pencina M.J., Massaro J.M., D'Agostino R.B. Sr, Newton-Cheh C., Yamamoto J.F., Magnani J.W., Tadros T.M., et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): A community-based cohort study. Lancet 2009;373:739-745.
28. D'Agostino R.B. Sr, Vasan R.S., Pencina M.J., Wolf P.A., Cobain M., Massaro J.M., Kannel W.B. General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation 2008;117: 743-753. (Pubitemid 351640675)
29. Butler J., Mooyaart E.A., Dannemann N., Bamberg F., Shapiro M.D., Ferencik M., Brady T.J., Hoffmann U. Relation of the metabolic syndrome to quantity of coronary atherosclerotic plaque. Am J Cardiol 2008;101:1127-1130.
30. Wang T.J., Massaro J.M., Levy D., Vasan R.S., Wolf P.A., D'Agostino R.B., Larson M.G., Kannel W.B., Benjamin E.J. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: The Framingham Heart Study. JAMA 2003;290:1049-1056. (Pubitemid 37430445)
31. Mogulkoc N., Brutsche M.H., Bishop P.W., Greaves S.M., Horrocks A.W., Egan J.J. Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation. Am J Respir Crit Care Med 2001;164: 103-108. (Pubitemid 33151306)
32. Lynch D.A., Godwin D.J., Safrin S., Starko K.M., Hormel P., Brown K.K., Raghu G., King T.E. Jr, Bradford W.Z., Schwartz D.A., et al. High resolution computed tomography in idiopathic pulmonary fibrosis: Diagnosis and prognosis. Am J Respir Crit Care Med 2005;172:488-493. (Pubitemid 41117395)